28274612|t|Effects of obesity on IL-33 / ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats
28274612|a|Suppression of tumorigenicity 2 (ST2) mediates the effect of Interleukin-33 (IL-33). Few data are reported on the relationship between IL-33 / ST2 and obesity. We aimed to investigate effects of obesity on IL-33 / ST2 system in heart, adipose tissue and liver in a rodent model of obesity. The relationship of cardiac expression of IL-33 / ST2 system with natriuretic peptides (NPs) system and inflammatory mediators was also studied. mRNA expression of IL-33 / ST2 system was evaluated in cardiac, adipose and hepatic biopsies from obese Zucker rats (O) and controls (CO). Expression levels of sST2 was significantly lower in O rats compared with CO (p<0.05) in all tissues. Besides, the mRNA levels of IL-33 decreased significant in fat of O respect to CO, while, expression levels of ST2L was significantly higher in liver of CO than in O. A strong relationship of IL-33 / ST2 with NPs and classical inflammatory mediators was observed in cardiac tissue. Expression of sST2 in cardiac, adipose and liver tissue decreased in O compared with controls, suggesting an involvement for IL-33 / ST2 system in molecular mechanisms of obesity. The strong relationships with NP systems and inflammatory mediators could suggest an involvement for IL-33 / ST2 in molecular pathways leading to cardiac dysfunction and inflammation associated with obesity.
28274612	0	7	Effects	T080	C1280500
28274612	11	18	obesity	T047	C0028754
28274612	22	27	IL-33	T116,T123	C2976122
28274612	30	33	ST2	T116,T192	C3849696
28274612	34	40	system	T169	C0449913
28274612	44	49	heart	T023	C0018787
28274612	51	65	adipose tissue	T024	C0001527
28274612	70	75	liver	T023	C0023884
28274612	77	82	study	T062	C0008972
28274612	90	108	experimental model	T170	C0086272
28274612	112	123	Zucker rats	T015	C0034719
28274612	124	155	Suppression of tumorigenicity 2	T116,T192	C3849696
28274612	157	160	ST2	T116,T192	C3849696
28274612	175	181	effect	T080	C1280500
28274612	185	199	Interleukin-33	T116,T123	C2976122
28274612	201	206	IL-33	T116,T123	C2976122
28274612	238	250	relationship	T080	C0439849
28274612	259	264	IL-33	T116,T123	C2976122
28274612	267	270	ST2	T116,T192	C3849696
28274612	275	282	obesity	T047	C0028754
28274612	308	315	effects	T080	C1280500
28274612	319	326	obesity	T047	C0028754
28274612	330	335	IL-33	T116,T123	C2976122
28274612	338	341	ST2	T116,T192	C3849696
28274612	342	348	system	T169	C0449913
28274612	352	357	heart	T023	C0018787
28274612	359	373	adipose tissue	T024	C0001527
28274612	378	383	liver	T023	C0023884
28274612	389	401	rodent model	T050	C1519106
28274612	405	412	obesity	T047	C0028754
28274612	418	430	relationship	T080	C0439849
28274612	434	441	cardiac	T024	C1272575
28274612	442	452	expression	T045	C1171362
28274612	456	461	IL-33	T116,T123	C2976122
28274612	464	467	ST2	T116,T192	C3849696
28274612	468	474	system	T169	C0449913
28274612	480	500	natriuretic peptides	T116,T121,T125	C1144709
28274612	502	505	NPs	T116,T121,T125	C1144709
28274612	507	513	system	T169	C0449913
28274612	518	540	inflammatory mediators	T038	C3155540
28274612	559	574	mRNA expression	T045	C1515670
28274612	578	583	IL-33	T028	C1825595
28274612	586	589	ST2	T028	C1420442
28274612	590	596	system	T169	C0449913
28274612	614	621	cardiac	T060	C0189784
28274612	623	630	adipose	T024	C0001527
28274612	635	651	hepatic biopsies	T060	C0193388
28274612	657	674	obese Zucker rats	T015	C0034719
28274612	676	677	O	T015	C0034719
28274612	683	691	controls	T096	C0009932
28274612	693	695	CO	T096	C0009932
28274612	698	708	Expression	T045	C1171362
28274612	719	723	sST2	T116,T192	C3852857
28274612	751	757	O rats	T015	C0034719
28274612	772	774	CO	T096	C0009932
28274612	791	798	tissues	T024	C0040300
28274612	813	817	mRNA	T114,T123	C0035696
28274612	828	833	IL-33	T028	C1825595
28274612	866	867	O	T015	C0034719
28274612	879	881	CO	T096	C0009932
28274612	890	900	expression	T045	C0017262
28274612	911	915	ST2L	T028	C1416400
28274612	944	949	liver	T023	C0023884
28274612	953	955	CO	T096	C0009932
28274612	964	965	O	T015	C0034719
28274612	976	988	relationship	T080	C0439849
28274612	992	997	IL-33	T116,T123	C2976122
28274612	1000	1003	ST2	T116,T192	C3849696
28274612	1009	1012	NPs	T116,T121,T125	C1144709
28274612	1027	1049	inflammatory mediators	T038	C3155540
28274612	1066	1080	cardiac tissue	T024	C1272575
28274612	1082	1092	Expression	T045	C1171362
28274612	1096	1100	sST2	T116,T192	C3852857
28274612	1104	1111	cardiac	T024	C1272575
28274612	1113	1120	adipose	T024	C0001527
28274612	1125	1137	liver tissue	T023	C0023884
28274612	1151	1152	O	T015	C0034719
28274612	1167	1175	controls	T096	C0009932
28274612	1207	1212	IL-33	T116,T123	C2976122
28274612	1215	1218	ST2	T116,T192	C3849696
28274612	1219	1225	system	T169	C0449913
28274612	1229	1249	molecular mechanisms	T044	C1148560
28274612	1253	1260	obesity	T047	C0028754
28274612	1273	1286	relationships	T080	C0439849
28274612	1292	1294	NP	T116,T121,T125	C1144709
28274612	1295	1302	systems	T169	C0449913
28274612	1307	1329	inflammatory mediators	T038	C3155540
28274612	1363	1368	IL-33	T116,T123	C2976122
28274612	1371	1374	ST2	T116,T192	C3849696
28274612	1378	1396	molecular pathways	T044	C1704259
28274612	1408	1427	cardiac dysfunction	T033	C3277906
28274612	1432	1444	inflammation	T046	C0021368
28274612	1461	1468	obesity	T047	C0028754